Our special effects, liquid and solid colorants expand your design and processing flexibility for a wide range of aesthetic possibilities. OnColor™ FX™ Special Effect Colorants OnColor™ FX™ Special Effect Colorants

Screen Printing: Special Applications Choose from a wide array of special applications for your inks and dyes Screen Printing: Special Effects Tips

Specially developed for biopharmaceutical tubing, it contains nearly 40% first-generation biomass content and shows a PCF reduction of nearly 25% compared to standard Versaflex HC BT218 grades – calculated with Avient’s third-party certified PCF calculator. Other Specialized Materials Highlighted at Pharmapack 2024: Avient Corporation provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

CLEVELAND – January 15, 2021 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, will complete an expansion of existing production capabilities for color concentrates at its Binh Duong site in Vietnam by next month. Avient’s enhanced local turnaround for color concentrates will support middle to high end markets with consistent color quality, creative application of special effects, and unique colors to enhance product appeal and match branding requirements. Avient also offers color concentrates for biodegradable plastics PLA, PHA, PHBV, PBS, PBAT and special blends of those materials, which do not compromise the organic recyclability of the resins they enhance.

It takes various forms, such as slavery, servitude, forced and compulsory labour and human trafficking, all of which have in common the deprivation of a person's liberty by another in order to exploit them for personal or commercial gain. During 2024 we continued to work with our key supplies in order to clarify our expectations regarding their compliance with the Modern Slavery Act 2015 and any other applicable anti-slavery laws. Organisations are being challenged to operate in a more transparent fashion and are expected to disclose more information than ever before; with that in mind, ColorMatrix intends to drive greater disclosure from our suppliers in order to better understand our supply chain and to mitigate any risks related to modern slavery.

Texture mold surface for better release. Use a TPE with mold release.

Texture mold surface for better release. Use a TPE with mold release.

• Develop and maintain a competitive executive compensation program in order to attract and retain qualified executives and to provide incentives to management that reward pay for performance in attaining the Company’s goals and objectives. 2 • Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by the independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s annual incentive and long-term incentive compensation plans. • Review and approve (a) attainment levels under the Company’s annual incentive plan; (b) payments to executive officers of the Company under the annual incentive plan; and (c) payments to officers, senior managers and employees of the Company under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers. 3 Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Perform administrative functions with respect to the compensation of non-employee directors, including interpreting existing policy. • Review and approve (or approve and recommend to the Board for its approval) equity-based grants and awards to non-employee directors under the Company’s equity-based plans.

THE SOLUTION: EVOLVED TPEs PERFORM FOR HEALTHCARE APPLICATIONS Recent thermoplastic elastomer advancements give manufacturers the ability to use specialized TPEs for healthcare to modernize processing and minimize secondary operations. Because of their stringent regulatory compliance, healthcaregrade TPEs can help to bypass certain layers of red tape in order to get products to market faster.

Unless otherwise stated, Adjusted EBITDA figures included in this presentation exclude the impact of special items as defined in our quarterly earnings releases. In addition, operating income before the effect of special items is a component of Avient’s annual incentive plans and is used in debt covenant computations. We also monitor earnings (defined as net income from continuing operations) before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a supplement to our GAAP measures.